Sildenafil Tablet, Film Coated
Product Images NDC 72888-015

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 72888-015). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advagen Pharma Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sildenafil Tabs Usp 100mg 1000s

Sildenafil Tablets USP 100 mg film-coated tablets label with NDC 72888-017-00. The label shows a package size of 1000 tablets, distributed by Advagen Pharma Limited, Plainsboro, NJ, and manufactured by Rubicon Research Private Limited, Maharashtra, India. Includes storage instructions and warnings about keeping medication out of reach of children.*

FDA Label Image

Sildenafil Tablets 100 mg (NDC 72888-017-01)

Sildenafil Tablets USP 100 mg film-coated tablets package label showing NDC 72888-017-01. The label states 100 tablets per container, distributed by Advagen Pharma Limited, Plainsboro, NJ, and manufactured by Rubicon Research Private Limited, Maharashtra, India. Storage instructions and safety warnings are included, with a barcode on the right side.*

FDA Label Image

Sildenafil Tablets 100 mg (NDC 72888-017-30)

Label for Sildenafil Tablets, USP 100 mg film-coated tablets, in a package of 30 tablets. Distributed by Advagen Pharma Limited, Plainsboro, NJ, USA, and manufactured by Rubicon Research Private Limited, Maharashtra, India. The label includes storage instructions, dosage information disclaimer, and barcode.*

FDA Label Image

Sildenafil Tablets 25 mg (NDC 72888-015-30)

Sildenafil Tablets, USP 25 mg film-coated tablets packaging label showing a 30-tablet count. Label includes storage instructions, distributor Advagen Pharma Limited, and manufacturer Rubicon Research Private Limited. The label features a barcode and the National Drug Code (NDC) 72888-015-30, with text indicating prescription-only and caution to keep out of reach of children.*

FDA Label Image

Sildenafil Tabs Usp 25mg 500s

Label for Sildenafil Tablets, USP 25 mg film-coated tablets, packaged as 500 tablets. Distributed by Advagen Pharma Limited, Plainsboro, NJ, manufactured by Rubicon Research Private Limited, India. Includes storage instructions, dosage caution, and barcodes. The label displays the proprietary name Sildenafil and the strength 25 mg prominently in blue.*

FDA Label Image

Sildenafil Tabs Usp 50mg 1000s

Label for Sildenafil tablets USP 50 mg film-coated oral tablets. The label indicates the product contains sildenafil citrate equivalent to 50 mg sildenafil, distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India. The label includes storage instructions, quantity of 1000 tablets, and barcodes.*

FDA Label Image

Sildenafil Tablets 50 mg (NDC 72888-016-01)

Sildenafil Tablets USP 50 mg film-coated tablets packaging label. The label states the product contains sildenafil citrate equivalent to 50 mg sildenafil per tablet, with a package count of 100 tablets. It is distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India. Storage instructions and a barcode are also present on the label.*

FDA Label Image

Sildenafil Tablets 50 mg (NDC 72888-016-30)

Sildenafil Tablets USP 50 mg film-coated tablets in a carton label format. The label indicates each tablet contains sildenafil citrate USP equivalent to 50 mg sildenafil. The package contains 30 tablets. Distributed by Advagen Pharma Limited, Plainsboro, NJ, and manufactured by Rubicon Research Private Limited, Maharashtra, India. Includes storage instructions and a barcode.*

FDA Label Image

Sildenafil Citrate Structure (Sildenafil Tabs Usp Chem Structure)

Chemical structure of sildenafil, the active ingredient in SILDENAFIL tablets, showing its molecular arrangement including a sulfonamide group, piperazine ring, and carboxylic acid moieties.*

FDA Label Image

Figure 1 (Sildenafil Tabs Usp Figure 1)

A line graph comparing the systolic blood pressure changes (mm Hg) over 24 hours between Sildenafil 100 mg and placebo. The x-axis represents time post dose in hours, and the y-axis shows systolic blood pressure changes. Two lines track pressure variations for Sildenafil and placebo groups post-dose.*

FDA Label Image

Figure 2 (Sildenafil Tabs Usp Figure 2)

A line graph depicting the change in systolic blood pressure (SBP) in mmHg over 8 hours post dose, comparing the effects of Doxazosin with Placebo and Doxazosin with Sildenafil 25 mg. The x-axis represents time in hours post dose, and the y-axis shows the change in SBP. Two lines represent the two treatment groups.*

FDA Label Image

Figure 3 (Sildenafil Tabs Usp Figure 3)

A line graph comparing the change in systolic blood pressure (SBP) over time post dose in hours. Two lines represent the treatments: doxazosin with placebo and doxazosin with sildenafil 50 mg. The y-axis shows change in SBP in mmHg, and the x-axis shows time post dose from 0 to 8 hours.*

FDA Label Image

Figure 4 (Sildenafil Tabs Usp Figure 4)

A line graph depicting changes in mmHg over time after dosing (hours) comparing effects of Doxazosin combined with Sildenafil 100 mg versus Doxazosin combined with placebo. The x-axis shows time after dosing from 0 to 8 hours, and the y-axis shows pressure changes in mmHg ranging from -50 to 40.*

FDA Label Image

Figure 5 (Sildenafil Tabs Usp Figure 5)

A pharmacokinetic curve illustrating plasma concentration (ng/mL) of sildenafil over time post dose (hours) comparing commercial tablet and test treatment. The graph shows concentration peaking around 1 hour post dose and gradually declining over 24 hours for both treatments.*

FDA Label Image

Figure 6 (Sildenafil Tabs Usp Figure 6)

A bar graph titled 'Effect of Sildenafil on Maintenance of Erection by Baseline Score' displaying the percentage of patients at endpoint on the vertical axis and baseline score on the horizontal axis from 0 to 5. The graph uses multiple bars per baseline score to represent categories labeled 0 through 5.*

FDA Label Image

Figure 7 (Sildenafil Tabs Usp Figure 7)

A bar chart titled 'Effect of Placebo on Maintenance of Erection by Baseline Score' showing the percentage of patients at endpoint along the vertical axis and baseline scores from 0 to 5 on the horizontal axis. Multiple bars for each baseline score category indicate varying percentages, with a legend identifying categories from 0 to 5. The chart depicts patient response distribution to placebo based on baseline scores.*

FDA Label Image

Figure 8 (Sildenafil Tabs Usp Figure 8)

A bar chart illustrating the percentage of patients reporting improvement by treatment group, comparing placebo, and sildenafil at 25 mg, 50 mg, and 100 mg doses. The x-axis lists the treatment groups with sample sizes, and the y-axis shows the percentage of improvement from 0% to 100%, with higher percentages in the sildenafil groups compared to placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.